Rucaparib maintenance treatment for recurrent ovarian carcinoma: the effects of progression-free interval and prior therapies on efficacy and safety in the randomized phase III trial ARIEL3 Article

Industry Collaboration International Collaboration

cited authors

  • Clamp, Andrew R.; Lorusso, Domenica; Oza, Amit M.; Aghajanian, Carol; Oaknin, Ana; Dean, Andrew; Colombo, Nicoletta; Weberpals, Johanne, I; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert W.; Gancedo, Margarita Amenedo; Fong, Peter C.; Goh, Jeffrey C.; O'Malley, David M.; Armstrong, Deborah K.; Banerjee, Susana; Garcia-Donas, Jesus; Swisher, Elizabeth M.; Cameron, Terri; Goble, Sandra; Coleman, Robert L.; Ledermann, Jonathan A.

authors

Publication Date

  • July 1, 2021

webpage

published in

category

keywords

  • ovarian cancer

start page

  • 949

end page

  • 958

volume

  • 31

issue

  • 7